“…Data came to show that the risk of COVID-19-related elective surgical mortality at the beginning of the pandemic was as high as 20-50% (10), and, as Dolan et al correctly point out, lung cancer patients were at a particularly high risk of COVID-19-related morbidity and mortality, both because of pre-existing comorbidity but also because of the direct effects of surgery on the lung and the immune system (1,6). The rates of postoperative COVID-19 infection following elective lung resection ranged from 0% (1,7), to as high as 28.5% (8), while the mortality rate in these patients was upwards of 40% (3,(6)(7)(8)(10)(11)(12).…”